Dr. Uday Saxena is currently a Co-Founder of start-up Biotech Company, ReaGene Biosciences. He has held Executive and Leadership positions at Parke-Davis in Ann Arbor, AtheroGenics in Atlanta (VP Drug Discovery), Dr. Reddy’s Laboratories (Chief Scientific Officer, US and India) and Kareus Therapeutics (CEO).
He has a PhD in Biochemistry from Memorial University and Post-doctoral training at Columbia University. He was associated with the Team at Parke-Davis that discovered Lipitor/atorvastatin, the largest selling (peak sales of $17 billion dollars) drug in pharma business. He lead teams that brought several drug candidates from an idea into the clinic.
Dr.Saxena’s current research interests are translational product discovery in metabolic diseases and oncology. His passion is to continue being an entrepreneur having initiated biotech companies in the US and India. He is one of the few executives who combine excellence in science as well as business side of pharma including being part of a start-up which was successfully listed on wall street (NASDAQ). He serves as a review member/Mentor to several DBT panels as well as IKP and CSIR programs. He is a well known speaker in International and National platforms and recipient of academic and Industry honors. He enjoys spending time with his family followed by watching and writing about cricket and science in that order.